Medical
Immune Therapeutics Labeled as a Pioneer in Forbes Article Discussing Booming Pet Care Industry
ORLANDO, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - - Immune Therapeutics, Inc. (OTCQB: IMUN), a...
Read moreRenown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board
ORLANDO, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune Therapeutics", "IMUN" or...
Read more
Precision Therapeutics Reports Second Quarter 2018 Financial Results
Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end of 2018 MINNEAPOLIS, Aug. 14, 2018...
Read more
eWellness is Developing a Tokenized Telehealth Payment System for the Healthcare Insurance Industry Update
Culver City, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the...
Read morePrecision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform
MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial...
Read moreImmune Therapeutics Adds Former United States Assistant Surgeon General Dr. Roscoe Moore to Board of Directors
ORLANDO, Fla., Aug. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Immune Therapeutics, Inc. (OTC: IMUN) (IMUN) ("Immune" “IMUN” or...
Read more
HedgePath Pharmaceuticals Announces Positive FDA Feedback from FDA Type-C Meeting and Files Pre-NDA Meeting Request
FDA has confirmed HPPI's clinical and regulatory pathway for SUBA BCCNS and provided further guidance for anticipated NDA submission PR...
Read morePrecision Therapeutics Receives Approval of Delisting Request from German Stock Exchange
MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial...
Read more
© Copyright 2019 PublicWire.com